BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress.
Initial detection of bladder cancer and surveillance for cancer recurrence and progression are central topics in the field of urologic oncology. A session at the 3rd Annual Bladder Cancer Think Tank Meeting focused on urine-based markers for bladder cancer screening and surveillance. Here, we review the key points from the presentations, as well as the recommendations from a working group tasked with critically evaluating the information discussed in the session. Although the practicality of markers has been challenged, the resounding consensus was that continued research efforts directed at developing and evaluating markers for screening and early detection are warranted.
Robinson
Victoria L
VL
Department of Surgery, The University of Chicago, Chicago, IL 60637, USA. vlrobins@uchicago.edu
Porter
Michael
M
Messing
Edward
E
Fradet
Yves
Y
Kamat
Ashish M
AM
Lotan
Yair
Y
D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000235:genetics*
D014408:Biomarkers, Tumor